Our goodwill is related to the acquisitions of Medicx Health in 2023, EvinceMed in 2022, RMDY Health, Inc. in 2019 and CareSpeak Communications in 2018. Goodwill is not amortizable for financial statement purposes.

Goodwill is tested for impairment at a reporting segment level at least annually, as of December 31, or on an interim basis if an event occurs or circumstances change. The Company considered indicators of impairment, and there were no triggering events identified, no indication of impairment of the Company’s goodwill and no impairment charges recorded during the three and six months ended June 30, 2026 or 2025.

Intangible assets included on the condensed consolidated balance sheets consist of the following:


	June 30, 2026
	Gross Carrying Amount		Accumulated Amortization		Net		Weighted Average Life Remaining
Patent rights	$	6,838	$	2,571	$	4,267	6.3
Technology assets	9,585		3,304		6,281		6.5
Customer relationships	34,923		6,761		28,162		12.1
Total intangible assets	$	51,346	$	12,636	$	38,710


	December 31, 2025
	Gross Carrying Amount		Accumulated Amortization		Net		Weighted Average Life Remaining
Patent rights	$	6,838	$	2,252	$	4,586	6.8
Technology assets	9,585		2,715		6,870		7.0
Customer relationships	34,923		5,583		29,340		12.6
Total intangible assets	$	51,346	$	10,550	$	40,796

The Company recorded impairment charges of $0 in the three and six months ended June 30, 2026 and $368 against the value of our intangible assets during the year ended December 31, 2025. In 2023, the Company licensed certain technology to a customer under a two-year agreement. Upon receiving notice that the contract would not be renewed in 2025, and as the Company no longer utilizes the underlying technology, the patents and tradenames associated with this technology

were determined to be fully impaired. Accordingly, an impairment charge of $368 was recorded and included in impairment charges within the condensed consolidated statements of operations and comprehensive income (loss).

The Company recorded amortization expense of $1,044 and $2,087 and $1,048 and $2,115 in the three and six months ended June 30, 2026 and 2025, respectively. Expected future amortization expense of the intangible assets as of June 30, 2026 is as follows:


Year ended December 31,
2026 (remainder)	$	2,069
2027	3,857
2028	3,709
2029	3,676
2030	3,676
Thereafter	21,723
Total	$	38,710